Literature DB >> 22366950

NKG2D signaling on CD8⁺ T cells represses T-bet and rescues CD4-unhelped CD8⁺ T cell memory recall but not effector responses.

Andrew Zloza1, Frederick J Kohlhapp, Gretchen E Lyons, Jason M Schenkel, Tamson V Moore, Andrew T Lacek, Jeremy A O'Sullivan, Vineeth Varanasi, Jesse W Williams, Michael C Jagoda, Emily C Bellavance, Amanda L Marzo, Paul G Thomas, Biljana Zafirova, Bojan Polić, Lena Al-Harthi, Anne I Sperling, José A Guevara-Patiño.   

Abstract

CD4-unhelped CD8(+) T cells are functionally defective T cells primed in the absence of CD4(+) T cell help. Given the co-stimulatory role of natural-killer group 2, member D protein (NKG2D) on CD8(+) T cells, we investigated its ability to rescue these immunologically impotent cells. We demonstrate that augmented co-stimulation through NKG2D during priming paradoxically rescues memory, but not effector, CD8(+) T cell responses. NKG2D-mediated rescue is characterized by reversal of elevated transcription factor T-box expressed in T cells (T-bet) expression and recovery of interleukin-2 and interferon-γ production and cytolytic responses. Rescue is abrogated in CD8(+) T cells lacking NKG2D. Augmented co-stimulation through NKG2D confers a high rate of survival to mice lacking CD4(+) T cells in a CD4-dependent influenza model and rescues HIV-specific CD8(+) T cell responses from CD4-deficient HIV-positive donors. These findings demonstrate that augmented co-stimulation through NKG2D is effective in rescuing CD4-unhelped CD8(+) T cells from their pathophysiological fate and may provide therapeutic benefits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22366950      PMCID: PMC3436127          DOI: 10.1038/nm.2683

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  56 in total

1.  CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes.

Authors:  Edith M Janssen; Edward E Lemmens; Tom Wolfe; Urs Christen; Matthias G von Herrath; Stephen P Schoenberger
Journal:  Nature       Date:  2003-02-09       Impact factor: 49.962

2.  The role of the NKG2D immunoreceptor in immune cell activation and natural killing.

Authors:  Amanda M Jamieson; Andreas Diefenbach; Christopher W McMahon; Na Xiong; James R Carlyle; David H Raulet
Journal:  Immunity       Date:  2002-07       Impact factor: 31.745

3.  Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events.

Authors:  Peter O Krutzik; Garry P Nolan
Journal:  Cytometry A       Date:  2003-10       Impact factor: 4.355

4.  Immunology. CD8 T cells remember with a little help.

Authors:  Susan M Kaech; Rafi Ahmed
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

5.  Requirement for CD4 T cell help in generating functional CD8 T cell memory.

Authors:  Devon J Shedlock; Hao Shen
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

6.  A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.

Authors:  Christine Bourgeois; Benedita Rocha; Corinne Tanchot
Journal:  Science       Date:  2002-09-20       Impact factor: 47.728

7.  A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.

Authors:  Andreas Diefenbach; Jennifer K Hsia; Ming-Yu B Hsiung; David H Raulet
Journal:  Eur J Immunol       Date:  2003-02       Impact factor: 5.532

8.  Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells.

Authors:  Anthony M Byers; Christopher C Kemball; Janice M Moser; Aron E Lukacher
Journal:  J Immunol       Date:  2003-07-01       Impact factor: 5.422

9.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

10.  NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules.

Authors:  Melissa Lodoen; Kouetsu Ogasawara; Jessica A Hamerman; Hisashi Arase; Jeffrey P Houchins; Edward S Mocarski; Lewis L Lanier
Journal:  J Exp Med       Date:  2003-05-19       Impact factor: 14.307

View more
  31 in total

1.  Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer.

Authors:  Jenna H Newman; David J Augeri; Rachel NeMoyer; Jyoti Malhotra; Elaine Langenfeld; Charles B Chesson; Natalie S Dobias; Michael J Lee; Saeed Tarabichi; Sachin R Jhawar; Praveen K Bommareddy; Sh'Rae Marshall; Evita T Sadimin; John E Kerrigan; Michael Goedken; Christine Minerowicz; Salma K Jabbour; Shengguo Li; Mary O Carayannopolous; Andrew Zloza; John Langenfeld
Journal:  Oncogene       Date:  2018-04-06       Impact factor: 9.867

Review 2.  Functions of NKG2D in CD8+ T cells: an opportunity for immunotherapy.

Authors:  Kushal Prajapati; Cynthia Perez; Lourdes Beatriz Plaza Rojas; Brianna Burke; Jose A Guevara-Patino
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

Review 3.  T Cells Going Innate.

Authors:  Midas Seyda; Abdallah Elkhal; Markus Quante; Christine S Falk; Stefan G Tullius
Journal:  Trends Immunol       Date:  2016-07-08       Impact factor: 16.687

Review 4.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

5.  Superior induction and maintenance of protective CD8 T cells in mice infected with mouse cytomegalovirus vector expressing RAE-1γ.

Authors:  Tihana Trsan; Andreas Busche; Maja Abram; Felix M Wensveen; Niels A Lemmermann; Maja Arapovic; Marina Babic; Adriana Tomic; Mijo Golemac; Melanie M Brinkmann; Wiebke Jäger; Annette Oxenius; Bojan Polic; Astrid Krmpotic; Martin Messerle; Stipan Jonjic
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-19       Impact factor: 11.205

Review 6.  Bystander T Cells: A Balancing Act of Friends and Foes.

Authors:  Sarah K Whiteside; Jeremy P Snook; Matthew A Williams; Janis J Weis
Journal:  Trends Immunol       Date:  2018-11-06       Impact factor: 16.687

Review 7.  The multifaceted role of CD4(+) T cells in CD8(+) T cell memory.

Authors:  Brian J Laidlaw; Joseph E Craft; Susan M Kaech
Journal:  Nat Rev Immunol       Date:  2016-01-19       Impact factor: 53.106

8.  Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.

Authors:  Jessica Wagner; C Leah Kline; Lanlan Zhou; Kerry S Campbell; Alexander W MacFarlane; Anthony J Olszanski; Kathy Q Cai; Harvey H Hensley; Eric A Ross; Marie D Ralff; Andrew Zloza; Charles B Chesson; Jenna H Newman; Howard Kaufman; Joseph Bertino; Mark Stein; Wafik S El-Deiry
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

9.  Non-oncogenic Acute Viral Infections Disrupt Anti-cancer Responses and Lead to Accelerated Cancer-Specific Host Death.

Authors:  Frederick J Kohlhapp; Erica J Huelsmann; Andrew T Lacek; Jason M Schenkel; Jevgenijs Lusciks; Joseph R Broucek; Josef W Goldufsky; Tasha Hughes; Janet P Zayas; Hubert Dolubizno; Ryan T Sowell; Regina Kühner; Sarah Burd; John C Kubasiak; Arman Nabatiyan; Sh'Rae Marshall; Praveen K Bommareddy; Shengguo Li; Jenna H Newman; Claude E Monken; Sasha H Shafikhani; Amanda L Marzo; Jose A Guevara-Patino; Ahmed Lasfar; Paul G Thomas; Edmund C Lattime; Howard L Kaufman; Andrew Zloza
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

10.  T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Authors:  Jiemiao Hu; Chuang Sun; Chantale Bernatchez; Xueqing Xia; Patrick Hwu; Gianpietro Dotti; Shulin Li
Journal:  Clin Cancer Res       Date:  2018-02-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.